V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250007204 | 250005076 | 1.58 | 102 | Disease modification (D) | 2017-02-18 | 2017-02-18 | RUXOLITINIB | N | N | 250031486 | BENDAMUSTINE + RITUXIMAB |
| 250007205 | 250005077 | null | null | Curative (C) | 2016-07-01 | 2016-07-01 | Rituximab | N | N | 250031490 | RUXOLITINIB |
| 250007206 | 250005077 | 1.45 | 72 | Curative (C) | 2015-10-05 | 2015-10-10 | INTERFERON | N | N | 250031490 | RUXOLITINIB |
| 250007207 | 250005078 | 1.6 | 141.9 | Curative (C) | 2017-12-01 | 2017-12-01 | Docetaxel | null | N | 250031492 | TRIAL |
| 250007208 | 250005079 | 1.37 | 0 | Disease modification (D) | null | 2014-06-29 | Bendamustine+Rituximab (1st Course) | N | N | 250031498 | CHOP R |
| 250007209 | 250005079 | 1.71 | 72 | Palliative (P) | 2011-12-10 | 2014-08-18 | PEG INTERFERON | Y | N | 250031498 | RUXOLITINIB |
| 250007210 | 250005080 | 1.65 | null | Palliative (P) | null | 2014-01-08 | RUXOLITINIB | N | N | 250031503 | RUXOLITINIB |
| 250007211 | 250005080 | 1.75 | 78.5 | Disease modification (D) | 2014-10-04 | 2014-10-04 | RUXOLITINIB | N | null | 250031503 | RUXOLITINIB |
| 250007212 | 250005080 | 1.6 | 95.7 | Disease modification (D) | 2013-01-23 | 2013-01-23 | RUXOLITINIB | Y | N | 250031503 | RUXOLITINIB |
| 250007213 | 250005081 | null | 78.6 | Disease modification (D) | 2017-10-28 | 2017-10-28 | RUXOLITINIB | null | N | 250031513 | ATG + BUSULFAN + FLUDARABINE |
| 250007214 | 250005082 | 0 | null | Palliative (P) | 2014-04-20 | 2014-04-20 | IPM | N | N | 250031514 | TRIAL |
| 250007215 | 250005083 | 1.82 | 60 | Palliative (P) | null | 2013-01-21 | ANAGRELIDE | null | N | 250031516 | RITUXIMAB |
| 250007216 | 250005084 | 1.68 | 82.4 | Palliative (P) | 2018-04-17 | 2018-04-17 | BUSULFAN | 02 | null | 250031517 | RUXOLITINIB |
| 250007217 | 250005085 | 0 | null | Curative (C) | null | 2015-11-27 | BUSULFAN | null | null | 250031520 | ANAGRELIDE |
| 250007218 | 250005086 | 1.71 | 98 | Disease modification (D) | 2014-05-30 | 2014-06-03 | BUSULFAN | N | N | 250031521 | ANAGRELIDE |
| 250007219 | 250005087 | null | 32.8 | Palliative (P) | 2013-10-23 | 2013-10-29 | ANAGRELIDE | N | N | 250031522 | PEG INTERFERON |
| 250007220 | 250005088 | null | 55 | Palliative (P) | 2014-11-05 | 2014-11-05 | Busulfan Oral | 01 | null | 250031523 | NOT MATCHED |
| 250007221 | 250005088 | 1.65 | null | Palliative (P) | 2014-06-13 | 2014-06-13 | RUXOLITINIB | null | null | 250031523 | RUXOLITINIB |
| 250007222 | 250005089 | 1.72 | 77.7 | Palliative (P) | 2016-10-20 | 2016-10-27 | RUXOLITINIB | N | N | 250031530 | PEG INTERFERON |
| 250007223 | 250005090 | 1.5 | 50.05 | Adjuvant (A) | 2017-11-07 | 2017-11-07 | PEG INTERFERON | 02 | N | 250031531 | AZACITIDINE |
| 250007224 | 250005091 | 0 | 76 | null | 2013-05-17 | 2013-05-17 | RUXOLITINIB | N | N | 250031541 | RUXOLITINIB |
| 250007225 | 250005092 | 0 | 60 | Disease modification (D) | 2015-03-09 | 2015-03-09 | RUXOLITINIB | 02 | N | 250031543 | RUXOLITINIB |
| 250007226 | 250005093 | null | 46 | Palliative (P) | 2016-01-13 | 2016-01-17 | Imatinib 600mg | N | N | 250031545 | CHLORAMBUCIL |
| 250007227 | 250005094 | 1.76 | 62.3 | Palliative (P) | 2014-03-24 | 2014-03-24 | RUXOLITINIB | N | N | 250031552 | RITUXIMAB |
| 250007228 | 250005094 | null | 0 | Curative (C) | null | 2013-09-12 | RUXOLITINIB | N | N | 250031552 | IMATINIB |
| 250007229 | 250005095 | 1.46 | null | Disease modification (D) | null | 2014-02-03 | GEMCARBO | 99 | N | 250031561 | CHLVPP |
| 250007230 | 250005095 | 0 | 73.3 | Disease modification (D) | 2017-11-22 | 2017-12-04 | Rituximab | N | N | 250031561 | LENALIDOMIDE |
| 250007231 | 250005095 | 0 | 79.6 | Palliative (P) | null | 2015-10-12 | Trial Unspecified | Y | N | 250031561 | RUXOLITINIB |
| 250007232 | 250005096 | 1.6 | 70.3 | Disease modification (D) | 2015-09-23 | 2015-09-23 | Bortezomib + Cyclophos + Dex | N | N | 250031571 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 250007233 | 250005097 | null | null | Palliative (P) | 2016-05-15 | 2016-05-16 | CHOP R - 21 days | N | N | 250031573 | RUXOLITINIB |
| 250007234 | 250005098 | 1.75 | 0 | Adjuvant (A) | 2017-03-31 | 2017-04-20 | RUXOLITINIB | N | N | 250031579 | RUXOLITINIB |
| 250007235 | 250005099 | 1.65 | null | Palliative (P) | 2014-03-22 | 2014-03-22 | Trial Unspecified | 2 | N | 250031580 | TRIAL |
| 250007236 | 250005100 | 1.7 | null | Disease modification (D) | 2014-11-15 | 2014-11-15 | THALIDOMIDE | N | N | 250031586 | BUSULPHAN |
| 250007237 | 250005101 | 1.67 | 66 | Adjuvant (A) | 2018-01-25 | 2018-01-25 | INTERFERON | 02 | N | 250031587 | RUXOLITINIB |
| 250007238 | 250005101 | null | 99.4 | null | 2016-11-10 | 2016-11-01 | RUXOLITINIB | 02 | N | 250031587 | AZACITIDINE |
| 250007239 | 250011595 | 1.49 | 0 | Palliative (P) | 2016-05-26 | 2016-05-28 | Trial Unspecified | N | N | 250031591 | RUXOLITINIB |
| 250007240 | 250011595 | 1.56 | 0 | Disease modification (D) | 2016-10-04 | 2016-12-04 | RUXOLITINIB | N | N | 250031591 | RUXOLITINIB |
| 250007241 | 250011595 | 0 | 91.8 | Palliative (P) | 2013-03-30 | 2013-04-02 | Methotrexate Intrathecal (any age) | 02 | N | 250031591 | PEG INTERFERON |
| 250007242 | 250005102 | null | 61.6 | null | 2016-11-27 | 2016-11-27 | Rituximab | N | N | 250031597 | RUXOLITINIB |
| 250007243 | 250005102 | null | 73.8 | Palliative (P) | 2016-09-26 | 2016-09-26 | BUSULFAN | 02 | N | 250031597 | RUXOLITINIB |
| 250007244 | 250005103 | 1.55 | 79.6 | Neo-adjuvant (N) | 2015-08-15 | 2015-08-15 | RUXOLITINIB | N | N | 250031604 | PEG INTERFERON |
| 250007245 | 250005103 | 1.56 | null | null | 2017-12-22 | 2017-12-22 | ANAGRELIDE | null | null | 250031604 | ANAGRELIDE |
| 250007246 | 250005104 | 0 | 0 | Disease modification (D) | 2013-12-13 | 2013-12-13 | RUXOLITINIB | N | N | 250031610 | CHLORAMBUCIL |
| 250007247 | 250005104 | null | 53.6 | Neo-adjuvant (N) | 2016-01-14 | 2016-01-14 | RUXOLITINIB | 02 | N | 250031610 | RUXOLITINIB |
| 250007248 | 250005104 | 1.69 | 97.4 | Disease modification (D) | 2017-04-03 | 2017-04-18 | Rituximab | null | N | 250031610 | PEG INTERFERON |
| 250007249 | 250005105 | 1.7 | 80 | Disease modification (D) | 2017-04-26 | 2017-07-14 | RUXOLITINIB | N | N | 250031622 | PEG INTERFERON |
| 250007250 | 250009697 | 1.63 | null | Disease modification (D) | null | 2016-05-16 | RUXOLITINIB | null | null | 250031624 | RITUXIMAB |
| 250007254 | 250005107 | 1.66 | 66.5 | Curative (C) | 2017-05-06 | 2017-05-13 | RUXOLITINIB | N | N | 250031637 | NILOTINIB |
| 250007255 | 250005108 | null | null | null | 2014-07-30 | 2014-07-30 | IMATINIB | N | N | 250031638 | CHOP R |
| 250007256 | 250005109 | 1.83 | 0 | Palliative (P) | 2016-12-28 | 2016-12-28 | Rituximab | Y | N | 250031642 | ANAGRELIDE |